WGSNasdaqServices-Health ServicesFiscal year ends December 31
GeneDx Holdings Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$66.29+2.68 (+4.21%)
Close on Oct 19, 2026
- Market cap
- $1.97B
- P/E (TTM)
- –
- Dividend yield
- –
GeneDx Holdings Corp. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | – | – | – | – | – | – | – | – | – | – | – | $19.71M | – | – |
| Gene Dx | – | $437.47M | $423.09M | $398.88M | $360.81M | $327.95M | $302.29M | $265.11M | $238.84M | $215.14M | $194.38M | $186.79M | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic test revenue: | $443.99M | $432.21M | $416.67M | $393.58M | $357.47M | $326.81M | $302.16M | $263.18M | $237.71M | $214.91M | $195.65M | $199.79M | 97.7% | +24.2% |
| Patients with third-party insurance | $375.72M | $362.10M | $345.24M | $323.45M | $287.97M | $258.92M | $234.70M | $198.25M | $174.48M | $153.00M | $134.49M | $132.05M | 82.7% | +30.5% |
| Institutional customers | $66.02M | $68.56M | $70.07M | $68.47M | $68.01M | $66.05M | $65.12M | $62.75M | $61.06M | $60.11M | $59.50M | $63.26M | 14.5% | -2.9% |
| Other revenue | $10.43M | $10.47M | $10.87M | $8.61M | $4.85M | $3.33M | $3.29M | $4.05M | $5.95M | $6.94M | $6.91M | $6.71M | 2.3% | +115.2% |
| Self-pay patients | $2.25M | $1.55M | $1.36M | $1.66M | $1.50M | $1.85M | $2.34M | $2.17M | $2.17M | $1.80M | $1.67M | $4.48M | 0.5% | +50.8% |
By region
From the segment and revenue-disaggregation notes of GeneDx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.